Neurological
-
How is painful diabetic sensorimotor polyneuropathy associated to axonal swelling in T2D?
The axonal swelling ratio is not associated with the presence of painful diabetic sensorimotor polyneuropathy (DSP) in people with type…
Read More » -
New classification of cognitive phenotypes for sufferers with MS
A new classification of cognitive deficits in patients with multiple sclerosis (MS), according to the study results published in JAMA…
Read More » -
Galcanezumab reduces migraine days and disables pain-free signs
Galcanezumab, a calcitonin gene-related peptide (CGRP) monoclonal antibody, has been linked to a reduction in the frequency of migraine headache…
Read More » -
Lack of sleep, dysfunction associated to a better danger of dementia
Subjects ” sleep disorders HealthDay News – Very short sleep lengths and poor sleep increase the risk of dementia and…
Read More » -
Effectiveness of the COVID-19 vaccine after first use: Pfizer, Moderna, AstraZeneca
Pfizer In a letter to the editor published in the New England Journal of Medicine, Dr. Danuta M. Skowronski and…
Read More » -
THC Linked to Neuropsychiatric Aspect Results in Older Adults
Study data published on JAMA Network Open describe the potential adverse effects of therapeutic use of delta-9-tetrahydrocannabinol (THC) in older…
Read More » -
The ganglion stimulation of the dorsal root can cut back the continual ache syndrome with non-complex regional ache
Posterior root ganglion stimulation (DRGS) may be an effective treatment for people with non-complex regional pain diagnoses of regional pain…
Read More » -
FDA opinions sodium oxybate formulation for narcolepsy as soon as an evening
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for FT218, a once-a-night investigational…
Read More » -
Atabecestat has been related to dose-related cognitive deterioration in preclinical AD
Treatment with atabecestat, a non-selective oral β-secretase inhibitor, was associated with dose-related cognitive deterioration in patients with preclinical Alzheimer’s disease…
Read More » -
Megakaryocytes in cerebral vessels may cause neurological impairment in COVID-19
Megakaryocytes in cortical capillaries of patients with coronavirus disease (COVID) -19 can cause marked ischemic changes and lead to various…
Read More »